What is the Historic and Current Scenario of the Stereotactic Surgery Devices Market?
The stereotactic surgery devices market has seen considerable growth due to a variety of factors.
•The market size for stereotactic surgery devices has seen stable expansion in the past few years. The growth rate is set to rise from $21.8 billion in 2024 to $22.63 billion in 2025, marking a compound annual growth rate (CAGR) of 3.8%.
This upward trend in the historical phase can be linked to the transition towards less invasive procedures, the fusion of robotics and automation, the heightened request for precision and accuracy, and enhanced safety profiles.
What are the Forecasted Growth and Key Factors of the Stereotactic Surgery Devices Market?
The stereotactic surgery devices market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the market size for stereotactic surgery devices will experience substantial growth in the upcoming years. The value is predicted to reach "$28.89 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.3%.
This anticipated growth during the forecast period has been linked to several factors such as the increase in cancer cases, the integration of ai and machine learning, introduction to new medical specialties, growth in the elderly population, and an increase in treatment customization and personalization. Key trends predicted to emerge during this forecast period include enhancements in precision and accuracy, device miniaturization, developments in robotics and automation, personalized treatment strategies, and an increase in applications and procedures.
What Are the Critical Driver Fuelling the Stereotactic Surgery Devices Market's Growth?
The stereotactic surgical device market is expected to grow, fueled by the rising incidences of Parkinson's disease and epilepsy. Parkinson's disease, a condition marked by neurodegeneration, is typified by uncontrollable shaking, slow movement, and rigid muscles. On the other hand, epilepsy is a neurological disorder affecting the brain, leading to an increased likelihood of recurring, unwarranted seizures. Stereotactic surgical devices are employed in the treatment of movement disorders, epilepsy, pain and psychiatry, and particularly Parkinson's disease. For example, according to research from the Parkinson’s Foundation, a national non-profit organization based in New York, it is projected that in 2022, over 90,000 individuals will be newly diagnosed with Parkinson's annually in the United States. This indicates a 50% increase from the previous estimate of 60,000 diagnoses annually. The number of Parkinson's disease patients in the country is nearly one million but is expected to rise to 1.2 million by 2030. Consequently, the escalating occurrences of Parkinson's disease and epilepsy are propelling the expansion of the stereotactic surgical device market.
How Is the Stereotactic Surgery Devices Market segmented?
The stereotactic surgery devices market covered in this report is segmented –
1) By Product: Gamma Knife, Line Accelerator (LINAC) Machines, Proton Beam, CyberKnife
2) By Application: Brain Tumor Treatment, Arteriovenous Malformations Treatment, Parkinsons Disease, Epilepsy, Other Applications
3) By End User: Hospitals, Laboratories
Subsegments:
1) By Gamma Knife: Leksell Gamma Knife Perfexion, Leksell Gamma Knife Icon
2) By Line Accelerator (LINAC) Machines: Conventional LINAC, Image-Guided Radiation Therapy (IGRT) LINAC
3) By Proton Beam: Fixed Beam Proton Therapy Systems, Scanned Beam Proton Therapy Systems
4) By CyberKnife: CyberKnife M6 System, CyberKnife VSI System
Pre-Book The Stereotactic Surgery Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the Stereotactic Surgery Devices Market?
In the stereotactic surgical device market, technological innovation has become a prominent trend. To consolidate their market status, leading companies in the domain are inventing novel technologies. A case in point is Brainlab, a medical technology firm based in Germany that in May 2023 debuted a new product named ExacTrac Dynamic Surface. This product is characterized as a surface guided radiation therapy (SGRT) patient tracking and positioning system. The system brings together high-speed thermal surface tracking technology with an updated version of ExacTrac X-ray surveillance, thus enhancing flexibility and precision in patient positioning and monitoring for diverse treatments such as cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system projects a structured blue light pattern on the patient's surface, which two 3D cameras capture. Additionally, each point on the surface is marked with a thermal signature, and this is recorded by the third in-built camera.
Who Are the Key Players in the Stereotactic Surgery Devices Market?
Major companies operating in the stereotactic surgery devices market include:
• Alliance Oncology
• Micromar Industria Commercio Ltda.
• Adeor Medical AG
• Monteris Medical Holding AG
• Inomed Medizintechnik GmbH
• Ion Beam Applications S.A. (IBA)
• Elekta AB (publ)
• Varian Medical Systems Inc.
• Accuracy Incorporated
• Modus Medical Devices Inc.
• Koninklijke Philips N.V.
• Huiheng Group Co. Ltd.
• Mitsubishi Heavy Industries Ltd.
• GE Healthcare
• Siemens AG
• Medtronic plc
• Brainlab AG
• Renishaw plc
• Neuropace Inc.
• Microvention Inc.
• MR Solutions Ltd.
• RaySearch Laboratories AB
• Alpha Omega Engineering Inc.
• FHC Inc.
• Nexstim Plc
• Scopis GmbH
• IZI Medical Products LLC
• Integra LifeSciences Holdings Corporation
• Computerized Imaging Reference Systems Inc.
• MRI Interventions Inc.
• ZAP Surgical Systems Inc.
• Schaerer Medical USA Inc.
What Is The Most Dominant Region In The Stereotactic Surgery Devices Market?
North America was the largest region in the stereotactic surgery devices market in 2024. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
